Medirom Healthcare Technologies Inc.MRM

NasdaqConsumer SpendingServices-Personal Services
Price (close)
$0.75
Market cap
—
P/E
—
Revenue (FY)
$8.3B
Net income
$148.8M
Dividend yield
—
1-year total return
-48.3%
Net margin
1.8%
Revenue growth
21.5%
Debt / equity
2.01x

What Medirom Healthcare Technologies Inc. does.

We are one of the leading holistic health services providers in Japan. Medirom is a franchiser and operator of healthcare salons across Japan, an operator of luxury hair salons in select central Tokyo locations, a preferred platform partner for healthcare service providers and government entities to affect positive health outcomes, and a provider of healthcare technology platforms.

We operate three synergistic lines of businesses: (1) Relaxation Salon Segment; (2) Luxury Beauty Segment; and (3) Digital Preventative Healthcare Segment (HealthTech). By combining brand strength and core retail competencies, including a broad physical footprint in population dense areas across the country, with proprietary technologies and partnerships, our business provides unique, value-added healthcare services to our customers with scale, customization, and cross-network effects that we believe few other companies in the industry can emulate. As of December 31, 2024, all of our principal business activities were focused on Japan.

As of December 31, 2024, the Relaxation Salon Segment had 308 locations across Japan, located within the country’s major cities, primarily in the Tokyo metropolitan area. We utilize our proprietarily customized customer relationship management system to record customer data, facilitate reservations and point-of-sale and business intelligence functions at the 283 salons integrated into such system as of December 31, 2024. Our salons are generally located in metro stations/subways, shopping malls, plazas and high-traffic streets. The Relaxation Salon Segment is our core business and accounted for ¥7,446 million (US$47.3 million), or approximately 89.7% of our total revenue, for the year ended December 31, 2024 and ¥6,060 million (US$38.5 million), or approximately 88.8% of our total revenue, for the year ended December 31, 2023.

Revenue and profit, by fiscal year.

Fiscal year201920202021202220232024
Revenue$3.9B$3.3B$5.4B$7.0B$6.8B$8.3B
Net income$17.3M-$539.2M-$990.7M$149.0M$115.4M$148.8M
Free cash flow$464,000-$440.0M-$652.9M-$806.4M-$767.6M-$1.4B

More on MRM.

Figures from Medirom Healthcare Technologies Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.